Antihypertensive Self-titration in US Primary Care
Part of paid clinical trials in Somerville, Massachusetts.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT07869966
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 35 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Self-Titration — OTHERFollowing consent, patients will complete a brief baseline questionnaire, including questions about blood pressure knowledge. Staff will ensure that the patient has a validated BP cuff for home use, teach them how to use it, calibrate the cuff, and test entering values. Patients will proceed through the self-titration process for 6 months.
Study Details
The objective of this study is to pilot test self-titration intervention procedures. We are testing a new way to manage high blood pressure from home. In this study, patients will check their blood pressure at home and take steps to adjust their blood pressure medications if needed, following a plan outlined with a primary care doctor. Participation in this study will last up to 6 months. Participation will include a research visit to review the blood pressure management process. A primary care provider will also develop a medication plan for each participant to follow during the study and address any questions at their upcoming visit. During the study, each participant will be asked to check their blood pressure at home every day for 1-2 weeks a month using a study-provided blood pressure cuff. They will be asked to follow a set of instructions to request a medication change from their provider, based on their blood pressure readings. Participation may also include lab visits and additional visits with a primary care physician before making medication changes, if needed. There will also be a follow-up visit within 6 months.
Key Dates
- First listed
- Oct 13, 2026
- Start date
- Feb 28, 2027
- Status verified
- Oct 2026
- Primary completion
- Aug 31, 2027
- Completion
- Feb 29, 2028
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Self-Titration
Primary Outcome Measure
Change in BP (blood pressure) [ Time Frame: 180 days ]
Central Contacts
- Julie C Lauffenburger, PharmD, PhD857-282-1962
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mass General Brigham | Somerville | Massachusetts | 02150 | Julie C Lauffenburger, PharmD, PhD |
Find similar trials in Somerville, MA
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Palo Alto, California
- Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring DevicesRecruiting · Dynocardia, Inc · Newton, Massachusetts
- Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical StudyPHASE4 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts